title: Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.
authors.affiliation: Department of Immunology, Merck Palo Alto (formerly DNAX Research Institute), Palo Alto, CA 94304, USA.
authors.forename: Cheng-Chi
authors.initials: CC
authors.lastname: Chao
authors.forename: Shi-Juan
authors.initials: SJ
authors.lastname: Chen
authors.forename: Iannis E
authors.initials: IE
authors.lastname: Adamopoulos
authors.forename: Nicole
authors.initials: N
authors.lastname: Davis
authors.forename: Kyu
authors.initials: K
authors.lastname: Hong
authors.forename: Anna
authors.initials: A
authors.lastname: Vu
authors.forename: Sylvia
authors.initials: S
authors.lastname: Kwan
authors.forename: Laurence
authors.initials: L
authors.lastname: Fayadat-Dilman
authors.forename: Agelio
authors.initials: A
authors.lastname: Asio
authors.forename: Edward P
authors.initials: EP
authors.lastname: Bowman